I am an Immuno-oncology MD, PhD based in the Bay Area.
I am currently focused on developing immunotherapies, which include allogeneic CAR-T.
This is an alternate account created to deal with potential political conflicts in science-focused articles.
Academia has become increasingly politicized, and I do not wish my desire for unbiased edits to be misconstrued as political ideology from the left or the right, thereby potentially influencing the funding my grad students and postdocs depend on.